Stock Ratings / Consumer Discretionary / OPRX / earnings

UXIN (38) DHX (52) CNDT (29) ALIT (36) ⌘ Pro Terminal →

OptimizeRx Corporation (OPRX) Next Earnings Date & Expected ±10.7% Move

$9.37 +0.75% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $9.41

OptimizeRx Corporation (OPRX) earns a Roarable Rating of B- (Buy) with 70/100 RQD Confidence. High-quality cash engine (67% profit margin, 7% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

📊 Historical Track Record: Scores of 70/100 (B-) historically ranked in the Top 15% of excess returns over the next 90 days (+6.6% avg 90D alpha vs SPY • 68.1% hit rate) →

ROARABLE B- • BUY Cap $176.5M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on OPRX Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is OPRX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-01, OptimizeRx Corporation (NASDAQ: OPRX) is rated B- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 70/100 at a spot price of $9.37 (+0.75% 1D, market cap $176.5M). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 14/20, FRED Macro Regime Fit 18/20, and SEC Balance-Sheet Forensics 15/20. Across 1011 tracked Consumer Discretionary issuers, OPRX ranks #187 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does OPRX compare to UXIN and DHX in the Consumer Discretionary sector?

▼

Within the Consumer Discretionary sector (Business Services), OPRX carries a Roarable B- (70/100 RQD), trailing P/E of 34.4x, gross margin of 67.3%, and ROIC of 7.3%. By comparison, UXIN (Uxin Limited ADS) holds a D- grade (38/100 RQD, P/E N/A, ROIC -35.0%, cap $206.8M) and DHX (DHI Group Inc.) posts a D+ grade (52/100 RQD, P/E N/A, ROIC -7.4%, cap $210.2M). Among the 5-stock peer group, OPRX leads on earnings multiple (34.4x) while OPRX leads on capital efficiency (7.3% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for OPRX?

▼

Per OPRX's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001448431), OptimizeRx Corporation generated $109.4M in revenue (+18.8% YoY), $5.1M in net income, and $18.7M in free cash flow against $176.9M in total assets and $21.4M in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $9.41 (+0.38%)🧬 Cannibal Buyback (-2.08% YoY Shares)⚙️ Cash Engine: 14/20 (B-) • 17% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 70/100 (B-) historically ranked in the Top 15% of excess returns over the next 90 days (+6.6% avg 90D alpha vs SPY • 68.1% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERBUY • B-

3-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw C · Rk B+

Each axis scored 0–20

12M PRICE TARGET CONE+5.4% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for OPRX)Realized 20D OHLCV Swing Band: ±10.7%

Deterministic 5-Pillar Attribution (70/100 Composite)

🔍 WHY OPRX SCORES 70/100 (B-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Macro Regime Fit+18/20 pts (26% of score)

FRED Regime × Technicals: 29% of 52W Range • RSI-14 at 63.6 (BULLISH MOMENTUM)

▲ #2 Bullish Driver: Insider Conviction & Share Dilution+15/20 pts (21% of score)

SEC Form 4 / 13F Thermometer: 75% Net Buy • Cannibal Buyback (-2.08% YoY Shares)

▼ #1 Drag / Risk Factor: Whale & Options Positioning9/20 pts (-11 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-11 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C+$8.28+2.7% Next Q

Q2 (-2Q)

Grade C+$8.50+7.6% Next Q

Q3 (-1Q)

Grade B-$9.15+2.4% Next Q

Current

Grade B-$9.37+6.6% Hist 90D α

Trajectory: C+ (62) → B- (70)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the OPRX Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 70/100 (B-) score, OPRX faces multiple-compression risk if 34.4x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.08% YoY Shares) — any gross margin slip below 64.8% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($8.20) or 200D SMA ($7.30) invalidates the momentum regime and cuts Target Base ($9.88) toward Bear Floor ($7.68).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $OPRX• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “OPRX Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 70%NO 30%Trade / Inspect Odds →

NEXT EST. WINDOW: Dec 30, 2026 (~58 DAYS)

Historical OHLCV Volatility ±10.7% Swing Band

±$1.00 Expected Swing

MODEL EARNINGS SETUP GAUGE

OPRX Quantitative Pre-Earnings Setup: 70/100

Trailing EPS: $0.27 • YoY Revenue Growth: 18.8%

Model Bullish Setup (70/100)Model Risk Weight (30/100)

Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).

LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

Period	Filed	Revenue	Net Profit	Free Cash Flow	Gross Margin
FY 2025	2025-12-31	$109.4M	$5.1M	$18.7M	67.3%
FY 2024	2024-12-31	$92.1M	-$20.1M	$4.8M	64.5%
FY 2023	2023-12-31	$71.5M	-$17.6M	-$7.2M	67.3%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Options & Swing Structure Desk

Whale Flow & Momentum Playbook: Evaluating OPRX & AI Leaders Without Chasing Tops

✓Institutional whale strikes & implied earnings move audit on OPRX
✓How disciplined traders manage risk using pre-published trigger & invalidation levels
✓Includes nightly RQD rating-change & forensic signal email alerts on tracked leaders

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

OPRX // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +50.40%▲ ASCENDING CHANNEL

2026-10-30O $9.25H $9.37L $9.00C $9.37VOL 136.3K

RES: $9.86SUP: $8.33SMA50: $8.20SMA200: $7.30

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

OPRX Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 OPRX Butterfly Map → + Track OPRX →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

26.5%/yr Implied 5Y Growth

vs. +18.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on OPRX today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for OPRX. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for OPRX today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (OPRX)

Consumer Discretionary Rank #187 of 1011 ⚔️ UXIN vs OPRX Full Matrix →

1. Head-to-Head Consumer Discretionary Peer Comparison (OPRX vs. UXIN, DHX, CNDT, ALIT)

Industry: Business Services (90 Tracked Issuers)

Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, OptimizeRx Corporation (OPRX) ranks #187 by composite RQD confidence (70/100, grade B-) and #708 by equity capitalization ($176.5M). Within this direct 5-issuer industry benchmark cohort, OPRX leads on earnings valuation at 34.4x trailing P/E, while OPRX leads on capital efficiency and profitability with 7.3% ROIC and 67.3% gross margin. OPRX currently leads its immediate peer cohort in composite quantitative strength at 70/100 (B-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
OPRX ACTIVE OptimizeRx Corporation	B-	70/100	34.4x	67.3%	7.3%	+0.75%	$176.5M	Benchmark Subject
UXIN Uxin Limited ADS	D-	38/100	—	6.7%	-35.0%	-1.00%	$206.8M	/uxin-vs-oprx →
DHX DHI Group Inc.	D+	52/100	—	84.7%	-7.4%	-0.21%	$210.2M	/dhx-vs-oprx →
CNDT Conduent Incorporated	E	29/100	—	18.1%	-24.8%	-1.90%	$241.1M	/cndt-vs-oprx →
ALIT Alight Inc. (Class A)	D-	36/100	—	33.8%	-35.0%	+1.44%	$247.0M	/alit-vs-oprx →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001448431

In its most recent audited fiscal period (FY2025, filed 2025-12-31), OptimizeRx Corporation (OPRX) reported GAAP revenue of $109.4M (+18.8% vs. FY2024 revenue of $92.1M , and +53.0% cumulative change since FY2023) , GAAP net income of $5.1M, operating cash flow of $18.7M, and free cash flow of $18.7M (+290.6% YoY). On the balance sheet, OPRX closed FY2025 with $176.9M in total assets against $21.4M in total debt (Altman Z-Score: 2.68, Piotroski F-Score: 9/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$109.4M	$5.1M	$18.7M	$18.7M	$176.9M	$21.4M
FY2024 (FY)	2024-12-31	$92.1M	-$20.1M	$4.9M	$4.8M	$171.2M	$30.8M
FY2023 (FY)	2023-12-31	$71.5M	-$17.6M	-$7.2M	-$7.2M	—	—

3. OPRX Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is OPRX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does OPRX compare to UXIN and DHX in the Consumer Discretionary sector?

What are the biggest fundamental strengths and SEC risk factors for OPRX?

Where is OPRX trading relative to its 50-day, 200-day, and 52-week technical levels?

OPRX last traded at $9.37 (+0.75% on volume of 100,522 shares), positioning the stock +14.27% above its 50-day simple moving average ($8.20) and +28.36% above its 200-day simple moving average ($7.30). Across its 52-week range of $4.54 to $21.09, OPRX sits at the 29.2% percentile with a 14-day RSI of 63.6 (BULLISH MOMENTUM) and an implied next-earnings move of ±10.7% ($8.37 to $10.37).